Sulforaphane reduces the alterations induced by quinolinic acid: Modulation of glutathione levels

Neuroscience

Volumn 272, Issue , 2014, Pages 188-198

  Santana Martinez R A ^a   Galvan Arzate S ^a   Hernandez Pando R ^b   Chanez Cardenas M E ^a   Avila Chavez E ^b   Lopez Acosta G ^a   Pedraza Chaverri J ^c   Santamaria A ^a   Maldonado, P D ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Excitotoxicity; Glutathione; Neuroprotection; Quinolinic acid; Sulforaphane

Indexed keywords

BRAIN PROTEIN; CARBONYL DERIVATIVE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; QUINOLINIC ACID; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; SULFORAFAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STRIATAL DEGENERATION; TISSUE DISTRIBUTION; ANIMAL; DRUG EFFECTS; LIPID PEROXIDATION; METABOLISM; WISTAR RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; GLUTATHIONE; GLUTATHIONE REDUCTASE; ISOTHIOCYANATES; LIPID PEROXIDATION; MALE; NEURODEGENERATIVE DISEASES; QUINOLINIC ACID; RATS, WISTAR;

EID: 84901334716     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.04.043     Document Type: Article

References (46)

1. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973.
2. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci 2008, 108:227-238.
3. Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009, 390:191-214.
4. Bordelon Y.M., Chesselet M.F., Nelson D., Welsh F., Erecińska M. Energetic dysfunction in quinolinic acid-lesioned rat striatum. J Neurochem 1997, 69:1629-1639.
5. Colín-González A.L., Orozco-Ibarra M., Chánez-Cárdenas M.E., Rangel-López E., Santamaría A., Pedraza-Chaverri J., Barrera-Oviedo D., Maldonado P.D. Heme oxygenase-1 (HO-1) upregulation delays morphological and oxidative damage induced in an excitotoxic/pro-oxidant model in the rat striatum. Neuroscience 2013, 231:91-101.
6. Cragg B.G. What is the signal for chromatolysis?. Brain Res 1970, 23:1-21.
7. Cruz-Aguado R., Francis-Turner L., Díaz C.M., Antúnez I. Quinolinic acid lesion induces changes in rat striatal glutathione metabolism. Neurochem Int 2000, 37:53-60.
8. Dong X.X., Wang Y., Qin Z.H. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 2009, 30:379-387.
9. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000, 62:649-671.
10. Fimognari C., Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutat Res 2007, 635:90-104.
11. Guerrero-Beltrán C.E., Calderón-Oliver M., Martínez-Abundis E., Tapia E., Zarco-Márquez G., Zazueta C., Pedraza-Chaverri J. Protective effect of sulforaphane against cisplatin-induced mitochondrial alterations and impairment in the activity of NAD(P)H: quinone oxidoreductase 1 and γ glutamyl cysteine ligase: studies in mitochondria isolated from rat kidney and in LLC-PK1 cells. Toxicol Lett 2010, 199:80-92.
12. Guerrero-Beltrán C.E., Calderón-Oliver M., Pedraza-Chaverri J., Chirino Y.I. Protective effect of sulforaphane against oxidative stress: recent advances. Exp Toxicol Pathol 2012, 64:503-508.
13. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
14. Han J.M., Lee Y.J., Lee S.Y., Kim E.M., Moon Y., Kim H.W., Hwang O. Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 2007, 321:249-256.
15. Hissin P., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976, 74:214-226.
16. Jellinger K.A. Recent advances in our understanding of neurodegeneration. J Neural Transm 2009, 16:1111-1162.
17. Juge N., Mithen R.F., Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 2007, 64:1105-1127.
18. Kádár A., Wittmann G., Liposits Z., Fekete C. Improved method for combination of immunocytochemistry and Nissl staining. J Neurosci Methods 2009, 184:115-118.
19. Kleszczyński K., Ernst I.M., Wagner A.E., Kruse N., Zillikens D., Rimbach G., Fischer T.W. Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: Role of Nrf2-dependent gene expression and antioxidant enzymes. Pharmacol Res 2013, 10.1016/j.phrs.2013.09.009.
20. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010, 460:525-542.
21. Lee J.M., Calkins M.J., Chan K., Kan Y.W., Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003, 278:12029-12038.
22. Li B., Cui W., Liu J., Li R., Liu Q., Xie X.H., Ge X.L., Zhang J., Song X.J., Wang Y., Guo L. Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol 2013, 10.1016/j.expneurol.2013.10.002.
23. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995, 146:3-15.
24. Maldonado P.D., Molina-Jijón E., Villeda-Hernández J., Galván-Arzate S., Santamaría A., Pedraza-Chaverrí J. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin. J Neurosci Res 2010, 88:620-629.
25. McWalter G.K., Higgins L.G., McLellan L.I., Henderson C.J., Song L., Thornalley P.J., Itoh K., Yamamoto M., Hayes J.D. Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J Nutr 2004, 134:3499S-3506S.
26. Migliore L., Coppedè F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res 2009, 674:73-84.
27. Miller D.M., Singh I.N., Wang J.A., Hall E.D. Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic Biol Med 2013, 57:1-9.
28. Negrette-Guzmán M, Huerta-Yepez S, Medina-Campos ON, Zatarain-Barrón, Hernández-Pando R, Torres I, Tapia E, Pedraza-Chaverri J (2013a), Sulforaphane attenuates gentamicin-induced nephrotoxicity: role of mitochondrial protection. Evid Based Complement Alternat Med 2013:135314.
29. Negrette-Guzmán M., Huerta-Yepez S., Tapia E., Pedraza-Chaverri J. Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis. Free Radic Biol Med 2013, 65C:1078-1089.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego.
31. Pérez-De la Cruz V., Carrillo-Mora P., Santamaría A. Huntington's disease and mitochondrial alterations: emphasis on experimental models. J Bioenerg Biomembr 2010, 42:207-215.
32. Pérez-De La Cruz V., Carrillo-Mora P., Santamaría A. Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. Int J Tryptophan Res 2012, 5:1-8.
33. Ping Z., Liu W., Kang Z., Cai J., Wang Q., Cheng N., Wang S., Wang S., Zhang J.H., Sun X. Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res 2010, 1343:178-185.
34. Rodríguez E., Méndez-Armenta M., Villeda-Hernández J., Galván-Arzate S., Barroso-Moguel R., Rodríguez F., Ríos C., Santamaría A. Dapsone prevents morphological lesions and lipid peroxidation induced by quinolinic acid in rat corpus striatum. Toxicology 1999, 139:111-118.
35. Rodríguez-Martínez E., Camacho A., Maldonado P.D., Pedraza-Chaverrí J., Santamaría D., Galván-Arzate S., Santamaría A. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res 2000, 858:436-439.
36. Santamaría A., Ríos C. MK-801, an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci Lett 1993, 159:51-54.
37. Santamaría A., Jiménez-Capdeville M.E., Camacho A., Rodríguez-Martínez E., Flores A., Galván-Arzate S. In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. Neuroreport 2001, 12. 2693-1296.
38. Siebert A., Desai V., Chandrasekaran K., Fiskum G., Jafri M.S. Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J Neurosci Res 2009, 87. 1659-1569.
39. Soane L., Li Dai W., Fiskum G., Bambrick L.L. Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation. J Neurosci Res 2010, 88:1355-1363.
40. Syntichaki P., Tavernarakis N. The biochemistry of neuronal necrosis: rogue biology?. Nat Rev Neurosci 2003, 4:672-684.
41. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
42. Vauzour D., Buonfiglio M., Corona G., Chirafisi J., Vafeiadou K., Angeloni C., Hrelia S., Hrelia P., Spencer J.P. Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol Nutr Food Res 2010, 54:532-542.
43. White C.C., Viernes H., Krejsa C.M., Botta D., Kavanagh T.J. Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem 2003, 318:175-180.
44. Yoon H.Y., Kang N.I., Lee H.K., Jang K.Y., Park J.W., Park B.H. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol 2008, 75:2214-2223.
45. Zhao J., Kobori N., Aronowski J., Dash P.K. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 2006, 393:108-112.
46. Zhu H., Jia Z., Strobl J.S., Ehrich M., Misra H.P., Li Y. Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 2008, 8:115-125.